The coronavirus disease 2019 (COVID-19) is widely spread and remains a global pandemic. Limited evidence on the systematic evaluation of the impact of treatment regimens on antibody responses exists.
The objective function values obtained after applying Phase 1 and Phase 2(TDFM) matheuristics are given.The updated treatment days of existing patients obtained from Phase 1 are provided.The experimen
This randomized phase III study compares safety and efficacy of two sequence arms in advanced colorectal cancer: irinotecan and S-1 (IRIS) followed by oxaliplatin containing regimen (arm A), or l-leuc